|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
|
EP1690854A1
(en)
|
1999-03-12 |
2006-08-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
|
EP1466906A1
(en)
|
1999-03-12 |
2004-10-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
|
ID30176A
(id)
|
1999-03-12 |
2001-11-08 |
Boehringer Ingelheim Pharma |
Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
|
|
AU773218B2
(en)
|
1999-10-08 |
2004-05-20 |
Debiopharm International Sa |
Fab I inhibitors
|
|
US6703525B2
(en)
|
2000-02-16 |
2004-03-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Sulfonamide intermediates and methods of producing same
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
EP1560584B1
(en)
|
2001-04-06 |
2009-01-14 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
|
EP1381594A1
(en)
|
2001-04-13 |
2004-01-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Urea compounds useful as anti-inflammatory agents
|
|
WO2002096876A1
(en)
|
2001-05-25 |
2002-12-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
EP1427412A1
(en)
|
2001-09-13 |
2004-06-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Methods of treating cytokine mediated diseases
|
|
AU2002341921B2
(en)
|
2001-10-04 |
2007-05-31 |
Merck Sharp & Dohme Corp. |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
US20050101518A1
(en)
|
2002-01-18 |
2005-05-12 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-2 receptor
|
|
PL218692B1
(pl)
|
2002-01-22 |
2015-01-30 |
Warner Lambert Co |
Podstawiony 2-(pirydyn-2-yloamino)pirydo[2,3-d]pirymidyn-7-on oraz jego zastosowanie do leczenia zaburzenia lub stanu spowodowanego nieprawidłową proliferacją komórek
|
|
JPWO2003062234A1
(ja)
|
2002-01-23 |
2005-05-19 |
山之内製薬株式会社 |
キノキサリン化合物
|
|
US20040023961A1
(en)
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
WO2004030637A2
(en)
|
2002-10-01 |
2004-04-15 |
Merck & Co., Inc. |
Treatment of obesity and other disorders associated with excessive food intake
|
|
ATE409485T1
(de)
|
2003-03-17 |
2008-10-15 |
Affinium Pharm Inc |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
|
BRPI0413757A
(pt)
|
2003-08-22 |
2006-10-31 |
Boehringer Ingelheim Pharma |
métodos para o tratamento de copd e da hipertensão pulmonar
|
|
US20070027321A1
(en)
|
2003-09-02 |
2007-02-01 |
Kamenecka Theodore M |
Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
|
|
CN102060806A
(zh)
|
2003-09-11 |
2011-05-18 |
iTherX药品公司 |
细胞因子抑制剂
|
|
JP4946861B2
(ja)
|
2004-08-09 |
2012-06-06 |
アステラス製薬株式会社 |
ヒストンデアセチラーゼ（ｈｄａｃ）の阻害活性を有するヒドロキシアミド化合物
|
|
ES2338590T3
(es)
|
2005-09-06 |
2010-05-10 |
Glaxosmithkline Llc |
Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
|
|
DE602006012694D1
(de)
|
2005-09-06 |
2010-04-15 |
Glaxosmithkline Llc |
Benzimidazolthiophenverbindungen als plk-modulatoren
|
|
WO2007056023A2
(en)
|
2005-11-02 |
2007-05-18 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
EP1968972B1
(en)
|
2005-12-23 |
2012-11-28 |
F. Hoffmann-La Roche AG |
Aryl-isoxazolo-4-yl-oxadiazole derivatives
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
AU2007213018A1
(en)
|
2006-02-07 |
2007-08-16 |
Astellas Pharma Inc. |
N-hydroxyacrylamide compounds
|
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
CN101384586A
(zh)
*
|
2006-02-14 |
2009-03-11 |
诺华公司 |
Pi-3激酶抑制剂及其应用方法
|
|
US7855194B2
(en)
|
2006-03-27 |
2010-12-21 |
Hoffmann-La Roche Inc. |
Pyrimidine, quinazoline, pteridine and triazine derivatives
|
|
US20100075960A1
(en)
|
2006-06-02 |
2010-03-25 |
Kevin Kuntz |
Benzimidazole thiophene compounds
|
|
US7615643B2
(en)
|
2006-06-02 |
2009-11-10 |
Smithkline Beecham Corporation |
Benzimidazole thiophene compounds
|
|
WO2007146712A2
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
DE102007007751A1
(de)
|
2007-02-16 |
2008-08-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
DE102007035333A1
(de)
|
2007-07-27 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
GB0719644D0
(en)
|
2007-10-05 |
2007-11-14 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2010006457A
(es)
|
2007-12-19 |
2010-07-05 |
Amgen Inc |
Compuestos fusionados de piridina, pirimidina y triazina como inhibidores de ciclo celular.
|
|
US7683064B2
(en)
|
2008-02-05 |
2010-03-23 |
Roche Palo Alto Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
CA2728016C
(en)
|
2008-06-24 |
2017-02-28 |
F. Hoffmann-La Roche Ag |
Novel substituted pyridin-2-ones and pyridazin-3-ones
|
|
US8445505B2
(en)
|
2008-06-25 |
2013-05-21 |
Irm Llc |
Pyrimidine derivatives as kinase inhibitors
|
|
EP2321309A1
(en)
|
2008-06-25 |
2011-05-18 |
Ranbaxy Laboratories Limited |
Benzothiazoles and aza-analogues thereof use as antibacterial agents
|
|
CN102203083A
(zh)
|
2008-06-25 |
2011-09-28 |
Irm责任有限公司 |
作为激酶抑制剂的嘧啶衍生物
|
|
PE20110403A1
(es)
|
2008-07-31 |
2011-07-04 |
Genentech Inc |
Compuestos biciclicos fusionados de pirimidina en el tratamiento del cancer
|
|
BRPI0917791B1
(pt)
|
2008-08-22 |
2022-03-22 |
Novartis Ag |
Compostos de pirrolopirimidina como inibidores de cdk, bem como composição farmacêutica e combinação
|
|
US20110172217A1
(en)
|
2008-09-05 |
2011-07-14 |
Shionogi & Co., Ltd. |
Ring-fused morpholine derivative having pi3k-inhibiting activity
|
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
JO2885B1
(en)
|
2008-12-22 |
2015-03-15 |
ايلي ليلي اند كومباني |
Protein kinase inhibitors
|
|
WO2010075282A1
(en)
|
2008-12-22 |
2010-07-01 |
University Of Washington |
Molecular inhibitors of the wnt/beta-catenin pathway
|
|
US8299077B2
(en)
|
2009-03-02 |
2012-10-30 |
Roche Palo Alto Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
KR20120034592A
(ko)
|
2009-04-09 |
2012-04-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
Ｈｉｖ 복제의 저해제
|
|
KR101445458B1
(ko)
|
2009-06-04 |
2014-10-07 |
노파르티스 아게 |
１Ｈ-이미다조［４,５-ｃ］퀴놀리논 유도체
|
|
CN102573486A
(zh)
|
2009-06-08 |
2012-07-11 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
|
EP2467137A1
(en)
|
2009-08-19 |
2012-06-27 |
Ambit Biosciences Corporation |
Biaryl compounds and methods of use thereof
|
|
WO2011021678A1
(ja)
|
2009-08-21 |
2011-02-24 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011031934A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
UY33227A
(es)
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
|
|
MX2012011912A
(es)
|
2010-04-13 |
2012-11-16 |
Novartis Ag |
Combinacion que comprende un inhibidor de cinasa 4 dependiente de ciclina o cinasa dependiente de ciclia (cdk4/6) y un inhibidor de mtor para tratar cancer.
|
|
HUE027256T2
(en)
|
2010-09-13 |
2016-08-29 |
Novartis Ag |
Triazine-oxadiazoles
|
|
WO2012045124A1
(en)
|
2010-10-08 |
2012-04-12 |
Biota Europe Ltd |
Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
|
|
WO2012095781A1
(en)
|
2011-01-13 |
2012-07-19 |
Pfizer Limited |
Indazole derivatives as sodium channel inhibitors
|
|
CN102617548A
(zh)
|
2011-01-31 |
2012-08-01 |
北京赛林泰医药技术有限公司 |
作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用
|
|
JP2014513728A
(ja)
|
2011-05-17 |
2014-06-05 |
プリンシピア バイオファーマ インコーポレイテッド |
チロシンキナーゼ阻害剤としてのアザインドール誘導体
|
|
US9216173B2
(en)
|
2011-10-05 |
2015-12-22 |
Merck Sharp & Dohme Corp. |
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
EP2802576B1
(en)
|
2012-01-13 |
2018-06-27 |
Bristol-Myers Squibb Company |
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
|
|
WO2013106641A1
(en)
|
2012-01-13 |
2013-07-18 |
Bristol-Myers Squibb Company |
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
CN104169275B
(zh)
|
2012-01-13 |
2017-06-09 |
百时美施贵宝公司 |
用作激酶抑制剂的三唑取代的吡啶化合物
|
|
HUE036582T2
(hu)
|
2012-04-17 |
2018-07-30 |
Fujifilm Corp |
Nitrogéntartalmú heterociklusos vegyület vagy annak sója
|
|
US9376418B2
(en)
|
2012-06-22 |
2016-06-28 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
|
|
US8729263B2
(en)
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
CA2884766A1
(en)
|
2012-10-16 |
2014-04-24 |
Daniel Jon Burdick |
Serine/threonine kinase inhibitors
|
|
WO2014106800A2
(en)
|
2013-01-04 |
2014-07-10 |
Aurigene Discovery Technologies Limited |
Substituted 2-amino pyrimidine derivatives as kinase inhibitors
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
EP3029031A4
(en)
|
2013-07-30 |
2017-01-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2015098991A1
(ja)
|
2013-12-26 |
2015-07-02 |
東レ株式会社 |
Ｎ－アルキルアミド誘導体及びその医薬用途
|
|
WO2015112441A1
(en)
|
2014-01-22 |
2015-07-30 |
Merck Sharp & Dohme Corp. |
Metallo-beta-lactamase inhibitors
|
|
AU2015222865B2
(en)
|
2014-02-28 |
2019-06-20 |
Takeda Pharmaceutical Company Limited |
TYK2 inhibitors and uses thereof
|
|
US10087195B2
(en)
|
2014-05-28 |
2018-10-02 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Certain protein kinase inhibitors
|
|
WO2016015604A1
(en)
|
2014-07-26 |
2016-02-04 |
Sunshine Lake Pharma Co., Ltd. |
Compounds as cdk small-molecule inhibitors and uses thereof
|
|
WO2016022644A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
|
WO2016027904A1
(ja)
|
2014-08-22 |
2016-02-25 |
富士フイルム株式会社 |
Ｆｌｔ３変異陽性癌を処置するための医薬組成物、変異型ｆｌｔ３阻害剤およびそれらの応用
|
|
EP3191467B1
(en)
|
2014-09-12 |
2020-10-21 |
Novartis AG |
Compounds and compositions as kinase inhibitors
|
|
JP6672296B2
(ja)
|
2014-10-31 |
2020-03-25 |
ザ ジェネラル ホスピタル コーポレイション |
強力なγ−セクレターゼモジュレータ
|
|
WO2016089208A2
(en)
|
2014-12-04 |
2016-06-09 |
Stichting Maastricht Radiation Oncology "Maastro-Clinic" |
Sulfonamide, sulfamate and sulfamide derivatives of anti-cancer agents
|
|
JP6884102B2
(ja)
|
2015-02-09 |
2021-06-09 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
がんの治療のための化合物
|
|
EP3053577A1
(en)
|
2015-02-09 |
2016-08-10 |
F. Hoffmann-La Roche AG |
Compounds for the treatment of cancer
|
|
ES2930585T3
(es)
|
2015-02-27 |
2022-12-19 |
Nimbus Lakshmi Inc |
Inhibidores de TYK2 y usos de los mismos
|
|
MX385083B
(es)
|
2015-04-14 |
2025-03-14 |
Qurient Co Ltd |
Derivados de quinolina como inhibidores de tirosinas-cinasas de receptor de met de axl, mer y tyro 3 (tam rtk).
|
|
LT3305785T
(lt)
|
2015-05-29 |
2021-11-10 |
Teijin Pharma Limited |
Pirido[3,4-d]pirimidino dariniai ir jų farmaciniu požiūriu priimtinos druskos
|
|
US10695346B2
(en)
*
|
2015-06-26 |
2020-06-30 |
Dana-Farber Cancer Institute, Inc. |
4,6-pyrimidinylene derivatives and uses thereof
|
|
WO2017019804A2
(en)
|
2015-07-28 |
2017-02-02 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN106608879A
(zh)
|
2015-10-27 |
2017-05-03 |
甘李药业股份有限公司 |
一种蛋白激酶抑制剂及其制备方法和医药用途
|
|
MX382671B
(es)
|
2015-12-10 |
2025-03-13 |
Ptc Therapeutics Inc |
Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
|
|
EP3386981B1
(en)
|
2015-12-13 |
2021-10-13 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocycles useful as anti-cancer agents
|
|
AU2017232610B2
(en)
|
2016-03-16 |
2021-07-22 |
Plexxikon Inc. |
Compounds and methods for kinase modulation and indications therefore
|
|
AU2017254708B2
(en)
|
2016-04-22 |
2021-09-16 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use
|
|
CN109476635B
(zh)
|
2016-04-29 |
2021-07-13 |
Fgh生物科技公司 |
用于治疗疾病的二取代吡唑类化合物
|
|
CN109790143A
(zh)
|
2016-05-10 |
2019-05-21 |
C4医药公司 |
用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
|
|
CN112250669B
(zh)
|
2016-09-07 |
2022-02-25 |
江苏豪森药业集团有限公司 |
苯并咪唑类化合物激酶抑制剂及其制备方法和应用
|
|
AU2017370694A1
(en)
|
2016-12-08 |
2019-07-25 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for treating CDK4/6-mediated cancer
|
|
WO2018136202A2
(en)
|
2016-12-23 |
2018-07-26 |
Plexxikon Inc. |
Compounds and methods for cdk8 modulation and indications therefor
|
|
CA3058182A1
(en)
|
2017-03-27 |
2018-10-04 |
Cardurion Pharmaceuticals, Llc |
Heterocyclic compound
|
|
KR102444482B1
(ko)
|
2017-04-01 |
2022-09-16 |
셍커 파마슈티컬스 (지앙수) 엘티디. |
단백질 인산화효소 억제제로서의 1h-이미다조[4,5-h]퀴나졸린 화합물
|
|
CN111372611A
(zh)
|
2017-06-14 |
2020-07-03 |
Ptc医疗公司 |
修饰rna剪接的方法
|
|
CN109516989B
(zh)
|
2017-09-17 |
2021-12-31 |
上海美志医药科技有限公司 |
一类抑制并降解cdk的化合物
|
|
JP7270989B2
(ja)
|
2017-10-20 |
2023-05-11 |
ヴァンダービルト ユニバーシティー |
ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
|
|
EP3707138B1
(en)
|
2017-11-06 |
2022-07-13 |
Bristol-Myers Squibb Company |
Isofuranone compounds useful as hpk1 inhibitors
|
|
US11325896B2
(en)
|
2017-12-20 |
2022-05-10 |
Vanderbilt University |
Antagonists of the muscarinic acetylcholine receptor M4
|
|
MX2020006587A
(es)
|
2017-12-22 |
2020-12-10 |
Ravenna Pharmaceuticals Inc |
Derivados de aminopiridina como inhibidores de fosfatidilinositol fosfato cinasa.
|
|
CA3085460A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
AU2018392816B2
(en)
|
2017-12-22 |
2023-04-20 |
HiberCell Inc. |
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
AU2019216492A1
(en)
|
2018-02-02 |
2020-08-20 |
Vanderbilt University |
Antagonists of the muscarinic acetylcholine receptor M4
|
|
AU2019220746A1
(en)
|
2018-02-15 |
2020-08-27 |
Nuvation Bio Inc. |
Heterocyclic compounds as kinase inhibitors
|
|
JP7399870B2
(ja)
|
2018-03-27 |
2023-12-18 |
ピーティーシー セラピューティクス， インコーポレイテッド |
ハンチントン病を処置するための化合物
|
|
US12037323B2
(en)
|
2018-05-03 |
2024-07-16 |
Bristol-Myers Squibb Company |
Uracil derivatives as Mer-AXL inhibitors
|
|
LT3814357T
(lt)
|
2018-06-27 |
2024-06-25 |
Ptc Therapeutics, Inc. |
Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
|
|
AU2019309909A1
(en)
|
2018-07-23 |
2021-02-04 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use
|
|
BR122023024103A2
(pt)
*
|
2018-10-15 |
2024-02-20 |
Nurix Therapeutics, Inc. |
Compostos bifuncionais para degradação de btk por meio da via de proteossoma de ubiquitina, composição farmacêutica compreendendo os mesmos, e seus usos
|
|
DK3877052T3
(da)
*
|
2018-11-06 |
2023-09-25 |
Edgewise Therapeutics Inc |
Pyridazinonforbindelser og anvendelser deraf
|
|
WO2020109191A1
(en)
|
2018-11-27 |
2020-06-04 |
F. Hoffmann-La Roche Ag |
Aryl compounds for the treatment and prophylaxis of bacterial infection
|
|
US12415797B2
(en)
|
2018-11-30 |
2025-09-16 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic compound as CDK-HDAC double-channel inhibitor
|
|
US12358911B2
(en)
|
2018-12-07 |
2025-07-15 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic comipound as CDK-HDAC dual pathway inhibitor
|
|
EP3891149A4
(en)
|
2018-12-07 |
2022-09-07 |
Sunshine Lake Pharma Co., Ltd. |
RET INHIBITOR, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
|
|
WO2020132700A1
(en)
|
2018-12-21 |
2020-06-25 |
Fgh Biotech Inc. |
Methods of using inhibitors of srebp in combination with niclosamide and analogs thereof
|
|
AU2020204714A1
(en)
|
2019-01-04 |
2021-07-08 |
Praxis Biotech LLC |
Inhibitors of fibroblast activation protein
|
|
EP3920918A4
(en)
|
2019-02-05 |
2022-11-16 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING
|
|
JP7603595B2
(ja)
|
2019-02-06 |
2024-12-20 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
|
CN113661164B
(zh)
|
2019-04-08 |
2025-03-04 |
珠海宇繁生物科技有限责任公司 |
一种cdk激酶抑制剂及其应用
|
|
CA3138973A1
(en)
|
2019-05-05 |
2020-11-12 |
Qilu Regor Therapeutics Inc. |
Cdk inhibitors
|
|
AU2020277027A1
(en)
|
2019-05-13 |
2021-12-09 |
Ptc Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
TW202112784A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之𠳭唏并嘧啶衍生物
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|